- Home
- FUSB vs SERA Comparison
FUSB vs SERA Comparison
Compare FUSB & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FUSB | SERA |
|---|---|---|
| Founded | 1952 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.1M | 75.2M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FUSB | SERA |
|---|---|---|
| Price | $16.50 | $2.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.0K | ★ 30.9K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.72% | N/A |
| EPS Growth | N/A | ★ 32.32 |
| EPS | ★ 0.33 | N/A |
| Revenue | N/A | ★ $81,000.00 |
| Revenue This Year | N/A | $554.81 |
| Revenue Next Year | N/A | $517.27 |
| P/E Ratio | $50.71 | ★ N/A |
| Revenue Growth | N/A | ★ 5.19 |
| 52 Week Low | $10.47 | $1.56 |
| 52 Week High | $16.99 | $3.95 |
Technical Indicators
Market Signals| Indicator | FUSB | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 49.42 | 50.45 |
| Support Level | $15.75 | $1.68 |
| Resistance Level | $16.50 | $2.07 |
| Average True Range (ATR) | 0.24 | 0.18 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 0.00 | 43.39 |
Price Performance
Historical ComparisonAbout FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement accounts, and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.